Bristol-Myers Squibb takes Opdivo to China's FDA after lung cancer survival win
admin 1st December 2017 Uncategorised 0Bristol-Myers Squibb is still searching for an Opdivo approval in the all-important first-line lung cancer space. But in the meantime, it Friday touted strong results in previously treated Chinese patients.
More: Bristol-Myers Squibb takes Opdivo to China's FDA after lung cancer survival win
Source: fierce